jpbrody...
Let me weigh in briefly on this one, and if doing so I strike at the giblets of the shorts, so be it...
jpbrody, jpbrody, jpbrody, where have you been. You say CCSI has two ways to go...either market the "COLORMATE III" themselves or license the technology, and with respect to the latter, you say "IF they can do this..."
You feel ok? Have you done ANY research on this company? Do you have the slightest idea of what the hell they've been doing for the past six months? And folks wonder why CCSI has an outstanding short interest...I really don't mean to single you out, but it's folks like you who haven't done their homework that just makes one shake their head in total disbelief...
You've not a clue in the world what CCSI's business plan is, do you? You think at this point they're contemplating organizing a sales team from Des Moines, Iowa, to knock on hospital doors throughout the world? You think they're at the stage where they've come up with a one page business objective, mailing it out to big companies around the world, sitting back and hoping on hope that they'll get some positive feedback?
You think I'm now going to tell you what they have in fact been doing and accomplished? LOL. I love to see shorts SWEAT.
As indicated today in CCSI's press release, they are in "ongoing discussions with potential partners for international medical distribution of its new product and are currently conducting negotiations to reach definitive agreements." When the results of those negotiations are announced, you will see what kind of numbers we're talking about. As has been mentioned here before, unfortunately for you and me, CCSI has been negotiating under a number of confidentiality agreements, so we'll not have an oppotunity to "debate the numbers" until the numbers come out. It doesn't make ANY difference what you or I think is the potential market...it DOES matter what a potential partner thinks and is willing to commit to...and it's that revenue stream leading to a revenue model that the market will value CCSI's stock on... |
